Skip to content

Clinical and Histological Evaluation of Deproteinizated Bovine Bone Allograft and Lyophilized Equine Bone Allograft for Sinus Lift.

Clinical and Histological Evaluation of Demineralized Bone Allograft and Lyophilized Equine Bone Allograft for Sinus Lift: Double Blind, Parallel, Randomized Clinical Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02865590
Enrollment
16
Registered
2016-08-12
Start date
2011-06-30
Completion date
2015-10-31
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillary Sinus Floor Augmentation

Keywords

Maxillary Sinus/surgery, Bone Substitutes, Radiography, Panoramic

Brief summary

The sinus infiltration technique for sinus floor elevation has been used successfully when a reduced vertical height is available in the posterior maxilla. However, the effect of the different graft material on the volume and on the quality of new bone formed has not been fully investigated. The aim of this study is to evaluate the clinical and histological effect of a test material, lyophilized equine bone (Bio-gen®), compared with control material, deproteinized bovine bone (Endobon®), in the sinus lift techniques with lateral approach.

Interventions

DEVICEsinus lift with Lyophilized Equine Bone Allograft (Bio-gen , Bioteck s.p.a., Arcugnano (VI) - Italy)
DEVICESinus lift with deproteinized bovine bone allograft (Endobon Xenograft Granules, Zimmer Biomet, San Donato Milanese (MI) - Italy)

Sponsors

University of L'Aquila
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* bilateral atrophy of the maxilla; * bone ridge \<= 6mm

Exclusion criteria

* severe systemic diseas (ASA III -IV) bisphosphonate therapy or a history of up to 3 years history of radiation therapy to neck and head area sinusitis pregnancy subjects not able to consent to participate in the study.

Design outcomes

Primary

MeasureTime frame
Histomorphometric Evaluation of New Bone Formation.6 months

Participant flow

Participants by arm

ArmCount
Lyophilized Equine Bone Allograft
Sinus Lift with Lyophilized Equine Bone Allograft sinus lift with Lyophilized Equine Bone Allograft (Bio-gen , Bioteck s.p.a., Arcugnano (VI) - Italy)
8
Deproteinized Bovine Bone Allograft
Sinus lift with deproteinized bovine bone allograft Sinus lift with deproteinized bovine bone allograft (Endobon Xenograft Granules, Zimmer Biomet, San Donato Milanese (MI) - Italy)
8
Total16

Baseline characteristics

CharacteristicDeproteinized Bovine Bone AllograftLyophilized Equine Bone AllograftTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
8 Participants8 Participants16 Participants
Age, Continuous51 years
STANDARD_DEVIATION 6
51 years
STANDARD_DEVIATION 6
51 years
STANDARD_DEVIATION 6
Region of Enrollment
Italy
8 participants8 participants16 participants
Sex: Female, Male
Female
3 Participants3 Participants6 Participants
Sex: Female, Male
Male
5 Participants5 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 80 / 8
serious
Total, serious adverse events
0 / 80 / 8

Outcome results

Primary

Histomorphometric Evaluation of New Bone Formation.

Time frame: 6 months

Population: Caucasion patients aged ≥ 25 years with at least one atrophic posterior maxilla (distally from first bicuspid teeth) with a residual crest height ≤4 mm who need sinus lift augmentation for dental implant placement were eligible for the study.

ArmMeasureGroupValue (MEAN)Dispersion
Lyophilized Equine Bone AllograftHistomorphometric Evaluation of New Bone Formation.newly formed bone22.20 percentage of millimetersStandard Deviation 7.18
Lyophilized Equine Bone AllograftHistomorphometric Evaluation of New Bone Formation.marrow spaces50.77 percentage of millimetersStandard Deviation 7.59
Lyophilized Equine Bone AllograftHistomorphometric Evaluation of New Bone Formation.residual graft material27 percentage of millimetersStandard Deviation 6.75
Deproteinized Bovine Bone AllograftHistomorphometric Evaluation of New Bone Formation.newly formed bone22.84 percentage of millimetersStandard Deviation 7.34
Deproteinized Bovine Bone AllograftHistomorphometric Evaluation of New Bone Formation.marrow spaces46.20 percentage of millimetersStandard Deviation 14.3
Deproteinized Bovine Bone AllograftHistomorphometric Evaluation of New Bone Formation.residual graft material30.94 percentage of millimetersStandard Deviation 10.2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026